Methyl 3-fluoro-4'-(2-(1-(2-(methylsulfonamido)ethyl)-5-neopentyl-1H-imidazol-2-yl)ethyl)biphenyl-2-carboxylate

ID: ALA4464287

Chembl Id: CHEMBL4464287

PubChem CID: 155530555

Max Phase: Preclinical

Molecular Formula: C27H34FN3O4S

Molecular Weight: 515.65

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)c1c(F)cccc1-c1ccc(CCc2ncc(CC(C)(C)C)n2CCNS(C)(=O)=O)cc1

Standard InChI:  InChI=1S/C27H34FN3O4S/c1-27(2,3)17-21-18-29-24(31(21)16-15-30-36(5,33)34)14-11-19-9-12-20(13-10-19)22-7-6-8-23(28)25(22)26(32)35-4/h6-10,12-13,18,30H,11,14-17H2,1-5H3

Standard InChI Key:  ZWRCRQVQVRFDOL-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4464287

    ---

Associated Targets(Human)

BRS3 Tchem Bombesin receptor subtype-3 (700 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Brs3 Bombesin receptor subtype-3 (412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 515.65Molecular Weight (Monoisotopic): 515.2254AlogP: 4.40#Rotatable Bonds: 10
Polar Surface Area: 90.29Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.12CX Basic pKa: 7.52CX LogP: 4.54CX LogD: 4.23
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.40Np Likeness Score: -1.16

References

1. Kiyotsuka Y, Shimada K, Kobayashi S, Suzuki M, Akiu M, Asano M, Sogawa Y, Hara T, Konishi M, Abe-Ohya R, Izumi M, Nagai Y, Yoshida K, Abe Y, Takamori H, Takahashi H..  (2016)  Synthesis and biological evaluation of novel imidazol-1-ylacetic acid derivatives as non-brain penetrant bombesin receptor subtype-3 (BRS-3) agonists.,  26  (17): [PMID:27491709] [10.1016/j.bmcl.2016.07.056]

Source